<DOC>
	<DOCNO>NCT01134757</DOCNO>
	<brief_summary>The present study aim evaluate bronchial allergen challenge house dust mite alternaria . Firstly , year 2005 , 2006 , 2007 , 2008 2009 retrospectively review . Secondly , 2010-2013 , prospective part study patient undergo bronchial allergen challenge examine safety bronchial allergen challenge change allergen specific bronchial hyperreactivity allergen specific immunotherapy .</brief_summary>
	<brief_title>Safety Bronchial Allergen Challenge Predictors Positive Reaction .</brief_title>
	<detailed_description>Specific bronchial allergen challenge establish tool clinical practice research , support understand pathophysiology allergic asthma , analyse efficacy new therapy . However , preschool age data specific bronchial allergen challenge . Douglas ( 1 ) evaluate predictor positive response bronchial allergic challenge house dust mite grass pollen twelve 5-to 6-year-old atopic child . The statistically significant predictor extent atopy proven skin prick testing , specific IgE , symptom asthma , persistent atopic eczema . However , number patient small . Therefore , research need confirm finding . Further , nonspecific bronchial hyperreactivity find high positive predictive value positive reaction ( 2 ) . To best knowledge , aspect investigate child . This study examine retro- prospectively safety bronchial allergic challenge house dust mite , grass pollen alternaria . The retrospective part evaluate association early allergic reaction , skin prick testing , specific IgE , measurement exhale NO , spirometry/IOS bronchial methacholine challenge . The prospective part measure early allergic reaction ( EAR ) focus late allergic reaction ( LAR ) examine change allergen specific bronchial hyperreactivity allergen specific immunotherapy . The study consist two visit first year study one follow-up visit per year . At first visit , patient undergo skin prick testing , measurement exhale NO , spirometry/IOS bronchial methacholine challenge . At next visit specific bronchial allergen challenge perform blood sample take . After , patient measure hourly peak flow next 10-hours . This procedure repeat first second year allergen specific immunotherapy . The safety issue study publish separately . The change allergen specific bronchial hyperreactivity evaluate every year study .</detailed_description>
	<mesh_term>Bronchial Hyperreactivity</mesh_term>
	<criteria>Informed consent Age 5 18 year Known house dust mite alternaria allergy Age &lt; 5 year &gt; 18 year Lung function VC &lt; 80 % FEV1 &lt; 75 % Others chronic disease infection ( e.g. , HIV , tuberculosis , malignancy ) Pregnancy Treatment systemic corticosteroid Documented alcohol , substance , and/or drug abuse Incapability perform study procedure</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>EAR</keyword>
	<keyword>LAR</keyword>
	<keyword>BHR</keyword>
	<keyword>house dust mite</keyword>
	<keyword>alternaria</keyword>
</DOC>